Diagnose des Multiplen Myelom ONKO-Internetportal - 03 May 2016 Diagnose des Multiplen Myelom ... More
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high ... Nature - 22 Apr 2024 Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high ... ... More
Multiple Myeloma: What's a Therapy 'Line'? HealthTree - 29 Apr 2024 Multiple Myeloma: What's a Therapy 'Line'? ... More
15th International Myeloma Foundation gala raises over $675K Myeloma Research News - 30 Apr 2024 15th International Myeloma Foundation gala raises over $675K ... More
European Commission Approves Cilta-Cel for R/R Myeloma After at Least 1 Prior Line of Therapy OncLive - 22 Apr 2024 European Commission Approves Cilta-Cel for R/R Myeloma After at Least 1 Prior Line of Therapy ... More
Daratumumab Plus Standard Therapy for Multiple Myeloma National Cancer Institute (.gov) - 19 Jan 2024 Daratumumab Plus Standard Therapy for Multiple Myeloma ... More
The enduring neutrophil–stroma dance of multiple myeloma Nature - 10 Apr 2024 The enduring neutrophil–stroma dance of multiple myeloma ... More
Dr Anderson on the FDA ODAC Decision Regarding Cilta-Cel in R/R Multiple Myeloma OncLive - 29 Apr 2024 Dr Anderson on the FDA ODAC Decision Regarding Cilta-Cel in R/R Multiple Myeloma ... More
Rheological properties of blood in multiple myeloma patients | Scientific Reports Nature - 21 Feb 2024 Rheological properties of blood in multiple myeloma patients | Scientific Reports ... More
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review | Blood Cancer Journal Nature - 25 Jan 2024 Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review | Blood Cancer Journal ... More
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against ... Nature - 15 Apr 2024 In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against ... ... More
Redefining high risk multiple myeloma with an APOBEC/Inflammation-based classifier | Leukemia Nature - 09 Mar 2024 Redefining high risk multiple myeloma with an APOBEC/Inflammation-based classifier | Leukemia ... More
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study | Blood Cancer Journal Nature - 05 Mar 2024 Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study | Blood Cancer Journal ... More
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA ... Nature - 06 Mar 2024 Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA ... ... More
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with ... Nature - 20 Feb 2024 Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with ... ... More
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with ... Nature - 09 Nov 2023 Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with ... ... More
The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease Nature - 19 Mar 2024 The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease ... More
Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial Nature - 04 Jan 2024 Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial ... More
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma Nature - 08 Feb 2024 Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma ... More